FDA Approves ZAVZPRET Nasal Spray for Rapid Relief of Acute Migraine Symptoms on March 2023

by B Jamerson | Jul 23, 2024 | 2023 Approvals, Drug approvals

What is ZAVZPRET prescribed for?    ZAVZPRET is prescribed for the acute treatment of migraine with or without aura in adults. What is the name of the drug and what does it do?  Zavzpret (generic name: zavegepant), pronounced “zav-spret,” is a...

FDA Approves SKYCLARYS to Aid Friedreich’s Ataxia Patients on February 28, 2023

by B Jamerson | Jul 23, 2024 | 2023 Approvals, Drug approvals

What is SKYCLARYS  prescribed for?  SKYCLARYS is prescribed for the treatment of Friedreich’s ataxia in adults and adolescents aged 16 years and older. What is the name of the drug and what does it do?  SKYCLARYS is a medication for adults and...

FDA Approves FILSPARI to Aid Kidney Health in IgA Nephropathy on February 2023

by B Jamerson | Jul 23, 2024 | 2023 Approvals, Drug approvals

What is FILSPARI prescribed for?   FILSPARI is prescribed to reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk of rapid disease progression. What is the name of the drug and what does it do?  FILSPARI (generic name:...

Introducing POMBILITI: A New FDA-Approved Treatment for Late-Onset Pompe Disease as of September 28, 2023

by B Jamerson | Jul 22, 2024 | 2023 Approvals, Drug approvals

What is POMBILITI prescribed for?   POMBILITI is prescribed for the treatment of adult patients with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency) weighing ≥88 lbs and who are not improving on their current enzyme replacement...

EXXUA: A Groundbreaking Step for Treating Major Depression Approved on September 22, 2023

by B Jamerson | Jul 22, 2024 | 2023 Approvals, Drug approvals

What is EXXUA prescribed for?   EXXUA is  prescribed to treat major depressive disorder in adults.  What is the name of the drug and what does it do? EXXUA, pronounced EKS-shoo-uh, (generic name: gepirone)  is a new medication approved by the...